Healthcare -
Biotechnology - NASDAQ - US
$ 15.135
-2.29 %
$ 1.28 B
Market Cap
-9.34
P/E
LQDA - COST OF REVENUE
Cost of Revenue LQDA - Liquidia Corporation
2.89 M
LAST VALUE
-2.26%
2 YEAR CAGR
88.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR